Consistent with this, and in the context of Alzheimer’s disease (AD), a deficiency of CCR2 in a mouse model of AD reduced monocyte trafficking into the CNS, and this was associated with increased Aβ plaque burden and mortality [48]. This evidence concerns the gene CCR2 and Alzheimer disease.